Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice

European Journal of Immunology

Volumn 38, Issue 2, 2008, Pages 587-598

  Mayne, Christopher G ^a   Amanna, Ian J ^b   Nashold, Faye E ^a   Hayes, Colleen E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Autoimmunity; B lymphocytes; BAFF R; Lupus

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; B CELL MATURATION ANTIGEN; B CELL MATURATION DEFECT 1 PROTEIN; GENE PRODUCT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG; AUTOANTIBODY; B CELL ACTIVATING FACTOR; TNFRSF13C PROTEIN, MOUSE;

A/WYSNJ MOUSE; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DEATH; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GLOMERULUS CAPILLARY; HISTOPATHOLOGY; LYMPHOCYTE COUNT; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; WILD TYPE; A J MOUSE; ANIMAL; AUTOIMMUNE DISEASE; BIOSYNTHESIS; BLOOD; CHROMATIN; COMPARATIVE STUDY; GENETICS; HUMAN; IMMUNOLOGY; KIDNEY; METABOLISM; MOUSE MUTANT; MUTATION; PATHOLOGY; RADIATION CHIMERA; SIGNAL TRANSDUCTION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CHROMATIN; FEMALE; HUMANS; KIDNEY; MALE; MICE; MICE, INBRED A; MICE, MUTANT STRAINS; MUTATION; RADIATION CHIMERA; SIGNAL TRANSDUCTION;

EID: 42249095669     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737817     Document Type: Article

References (48)

1. Fairhurst, A. M., Wandstrat, A. E. and Wakeland, E. K., Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Adv. Immunol. 2006. 92: 1-69.
2. Hochberg, M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997. 40: 1725.
3. Marshak-Rothstein, A., Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006. 6: 823-835.
4. Goodnow, C. C., Sprent, J., Fazekas de St Groth, B. and Vinuesa, C. G., Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005. 435: 590-597.
5. Mackay, F., Sierro, F., Grey, S. T. and Gordon, T. P., The BAFF/ APRIL system: An important player in systemic rheumatic diseases. Curr. Dir. Autoimmun. 2005. 8: 243-265.
6. Zhang, J., Roschke, V., Baker, K. P., Wang, Z., Alarcon, G. S., Fessler, B. J., Bastian, H. et al., Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 2001. 166: 6-10.
7. Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W. et al., TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000. 404: 995-999.
8. Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W., French, D. M., Grewal, I. S. et al., BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 2002. 17: 515-524.
9. Strasser, A., Whittingham, S., Vaux, D. L., Bath, M. L., Adams, J. M., Cory, S. and Harris, A.W., Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 1991. 88: 8661-8665.
10. Strasser, A., The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 2005. 5: 189-200.
11. Thien, M., Phan, T. G., Gardam, S., Amesbury, M., Basten, A., Mackay, F. and Brink, R., Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004. 20: 785-798.
12. Lesley, R., Xu, Y., Kalled, S. L., Hess, D. M., Schwab, S. R., Shu, H. B. and Cyster, J. G., Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004. 20: 441-453.
13. Lentz, V. M., Cancro, M. P., Nashold, F. E. and Hayes, C. E., Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J. Immunol. 1996. 157: 598-606.
14. Hoag, K. A., Clise-Dwyer, K., Lim, Y. H., Nashold, F. E., Gestwicki, J., Cancro, M. P. and Hayes, C. E., A quantitative-trait locus controlling peripheral B-cell deficiency maps to mouse chromosome 15. Immunogenetics 2000. 51: 924-929.
15. Clise-Dwyer, K., Amanna, I. J., Duzeski, J. L., Nashold, F. E. and Hayes, C. E., Genetic studies of B-lymphocyte deficiency and mastocytosis in strain A/WySnJ mice. Immunogenetics 2001. 53: 729-735.
16. Amanna, I. J., Clise-Dwyer, K., Nashold, F. E., Hoag, K. A. and Hayes, C. E., Cutting edge: A/WySnJ transitional B cells overexpress the chromosome 15 proapoptotic Blk gene and succumb to premature apoptosis. J. Immunol. 2001. 167: 6069-6072.
17. Thompson, J. S., Bixler, S. A., Qian, F., Vora, K., Scott, M. L., Cachero, T. G., Hession, C. et al., Baff-R, a newly identified TNF receptor that specifically interacts with baff. Science 2001. 293: 2108-2111.
18. Yan,M., Brady, J. R., Chan, B., Lee, W. P., Hsu, B., Harless, S., Cancro, M. et al., Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 2001. 11: 1547-1552.
19. Harless, S. M., Lentz, V.M., Sah, A. P., Hsu, B. L., Clise-Dwyer, K., Hilbert, D. M., Hayes, C. E. and Cancro, M. P., Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr. Biol. 2001. 11: 1986-1989.
20. Amanna, I. J., Dingwall, J. P. and Hayes, C. E., Enforced bcl-x(L) gene expression restored splenic B lymphocyte development in BAFF-R mutant mice. J. Immunol. 2003. 170: 4593-4600.
21. Miller, D. J., Hanson, K. D., Carman, J. A. and Hayes, C. E., A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice. Eur. J. Immunol. 1992. 22: 373-379.
22. Miller, D. J. and Hayes, C. E., Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur. J. Immunol. 1991. 21: 1123-1130.
23. Hardy, R. R., B-1 B cell development. J. Immunol. 2006. 177: 2749-2754.
24. Lentz, V.M., Hayes, C. E. and Cancro, M. P., Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J. Immunol. 1998. 160: 3743-3747.
25. Shulga-Morskaya, S., Dobles, M., Walsh, M. E., Ng, L. G., MacKay, F., Rao, S. P., Kalled, S. L. and Scott, M. L., B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J. Immunol. 2004. 173: 2331-2341.
26. Gorelik, L., Cutler, A. H., Thill, G., Miklasz, S. D., Shea, D. E., Ambrose, C., Bixler, S. A. et al., Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J. Immunol. 2004. 172: 762-766.
27. Sasaki, Y., Casola, S., Kutok, J. L., Rajewsky, K. and Schmidt-Supprian, M., TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J. Immunol. 2004. 173: 2245-2252.
28. Carroll, M. C., A protective role for innate immunity in systemic lupus erythematosus. Nat. Rev. Immunol. 2004. 4: 825-831.
29. Ni, C. Z., Oganesyan, G., Welsh, K., Zhu, X., Reed, J. C., Satterthwait, A. C., Cheng, G. and Ely, K. R., Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: Implications for intracellular signaling regulation. J. Immunol. 2004. 173: 7394-7400.
30. Xu, L. G. and Shu, H. B., TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J. Immunol. 2002. 169: 6883-6889.
31. O'Connor, S., Shumway, S. D., Amanna, I. J., Hayes, C. E. and Miyamoto, S., Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. Mol. Cell. Biol. 2004. 24: 4895-4908.
32. Debnath, I., Roundy, K. M., Weis, J. J. and Weis, J. H., Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23. Mol. Immunol. 2007. 44: 2388-2399.
33. Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G. and Marshak-Rothstein, A., Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 2005. 204: 27-42.
34. von Bulow, G. U., van Deursen, J. M. and Bram, R. J., Regulation of the T-independent humoral response by TACI. Immunity 2001. 14: 573-582.
35. Boackle, S. A., Holers, V. M., Chen, X., Szakonyi, G., Karp, D. R., Wakeland, E. K. and Morel, L., Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 2001. 15: 775-785.
36. Huard, B., Arlettaz, L., Ambrose, C., Kindler, V., Mauri, D., Roosnek, E., Tschopp, J. et al., BAFF production by antigen-presenting cells provides T cell co-stimulation. Int. Immunol. 2004. 16: 467-475.
37. Ye, Q., Wang, L., Wells, A. D., Tao, R., Han, R., Davidson, A., Scott, M. L. and Hancock, W. W., BAFF binding toTcell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur. J. Immunol. 2004. 34: 2750-2759.
38. Groom, J. R., Fletcher, C. A., Walters, S. N., Grey, S. T., Watt, S. V., Sweet, M. J., Smyth, M. J. et al., BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J. Exp. Med. 2007. 204: 1959-1971.
39. Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J. and Browning, J. L., Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 1999. 190: 1697-1710.
40. Bynoe, M. S., Grimaldi, C. M. and Diamond, B., Estrogen up-regulates BCL-2 and blocks tolerance induction of naive B cells. Proc. Natl. Acad. Sci. USA 2000. 97: 2703-2708.
41. Kitching, A. R., Holdsworth, S. R., Ploplis, V. A., Plow, E. F., Collen, D., Carmeliet, P. and Tipping, P. G., Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J. Exp. Med. 1997. 185: 963-968.
42. Rosenkranz, A. R., Mendrick, D. L., Cotran, R. S. and Mayadas, T. N., P-selectin deficiency exacerbates experimental glomerulonephritis: A protective role for endothelial P-selectin in inflammation. J. Clin. Invest. 1999. 103: 649-659.
43. Mohan, C., Morel, L., Yang, P.,Watanabe, H., Croker, B., Gilkeson, G. and Wakeland, E. K., Genetic dissection of lupus pathogenesis: A recipe for nephrophilic autoantibodies. J. Clin. Invest. 1999. 103: 1685-1695.
44. Morel, L., Tian, X. H., Croker, B. P. and Wakeland, E. K., Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999. 11: 131-139.
45. Johnson, B. A., Ikeda, S., Pinto, L. H. and Ikeda, A., Reduced synaptic vesicle density and aberrant synaptic localization caused by a splice site mutation in the Rs1h gene. Vis. Neurosci. 2006. 23: 887-898.
46. Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M. et al., Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 1998. 92: 3780-3792.
47. Allman, D., Lindsley, R. C., DeMuth, W., Rudd, K., Shinton, S. A. and Hardy, R. R., Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cellmaturation. J. Immunol. 2001. 167: 6834-6840.
48. Cariappa, A., Tang, M., Parng, C., Nebelitskiy, E., Carroll, M., Georgopoulos, K. and Pillai, S., The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 2001. 14: 603-615.